Literature DB >> 26782330

Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD.

Lorraine V Kalia1, Anthony E Lang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26782330     DOI： 10.1038/nrneurol.2015.249

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

Review 1.  MDS clinical diagnostic criteria for Parkinson's disease.

Authors:  Ronald B Postuma; Daniela Berg; Matthew Stern; Werner Poewe; C Warren Olanow; Wolfgang Oertel; José Obeso; Kenneth Marek; Irene Litvan; Anthony E Lang; Glenda Halliday; Christopher G Goetz; Thomas Gasser; Bruno Dubois; Piu Chan; Bastiaan R Bloem; Charles H Adler; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 2.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 3.  Parkinson's disease.

Authors:  Lorraine V Kalia; Anthony E Lang
Journal:  Lancet       Date:  2015-04-19       Impact factor: 79.321

4.  α-Synuclein strains cause distinct synucleinopathies after local and systemic administration.

Authors:  W Peelaerts; L Bousset; A Van der Perren; A Moskalyuk; R Pulizzi; M Giugliano; C Van den Haute; R Melki; V Baekelandt
Journal:  Nature       Date:  2015-06-10       Impact factor: 49.962

5.  Vagotomy and subsequent risk of Parkinson's disease.

Authors:  Elisabeth Svensson; Erzsébet Horváth-Puhó; Reimar W Thomsen; Jens Christian Djurhuus; Lars Pedersen; Per Borghammer; Henrik Toft Sørensen
Journal:  Ann Neurol       Date:  2015-07-17       Impact factor: 10.422

6.  Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

Authors:  Lorraine V Kalia; Anthony E Lang; Lili-Naz Hazrati; Shinsuke Fujioka; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross; Vivianna M Van Deerlin; John Q Trojanowski; Howard I Hurtig; Roy N Alcalay; Karen S Marder; Lorraine N Clark; Carles Gaig; Eduardo Tolosa; Javier Ruiz-Martínez; Jose F Marti-Masso; Isidre Ferrer; Adolfo López de Munain; Samuel M Goldman; Birgitt Schüle; J William Langston; Jan O Aasly; Maria T Giordana; Vincenzo Bonifati; Andreas Puschmann; Margherita Canesi; Gianni Pezzoli; Andre Maues De Paula; Kazuko Hasegawa; Charles Duyckaerts; Alexis Brice; A Jon Stoessl; Connie Marras
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

7.  Parkinson disease and incidental Lewy body disease: Just a question of time?

Authors:  Diego Iacono; Maria Geraci-Erck; Marcie L Rabin; Charles H Adler; Geidy Serrano; Thomas G Beach; Roger Kurlan
Journal:  Neurology       Date:  2015-10-14       Impact factor: 9.910

8.  Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.

Authors:  Anke A Dijkstra; Pieter Voorn; Henk W Berendse; Henk J Groenewegen; Annemieke J M Rozemuller; Wilma D J van de Berg
Journal:  Mov Disord       Date:  2014-07-03       Impact factor: 10.338

9.  Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Authors:  Anette Schrag; Laura Horsfall; Kate Walters; Alastair Noyce; Irene Petersen
Journal:  Lancet Neurol       Date:  2014-11-27       Impact factor: 44.182

10.  Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.

Authors:  Rosalind F Roberts; Richard Wade-Martins; Javier Alegre-Abarrategui
Journal:  Brain       Date:  2015-03-01       Impact factor: 13.501
  10 in total
  56 in total

Review 1.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 2.  TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Neurobiol Dis       Date:  2018-05-28       Impact factor: 5.996

3.  6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson's Model.

Authors:  Xiufeng Wang; Heng Zhai; Fang Wang
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

Review 4.  Neuroprotection through G-CSF: recent advances and future viewpoints.

Authors:  Vikrant Rahi; Sumit Jamwal; Puneet Kumar
Journal:  Pharmacol Rep       Date:  2021-01-02       Impact factor: 3.024

5.  Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.

Authors:  Edna Grünblatt; Josefine Ruder; Camelia Maria Monoranu; Peter Riederer; Moussa Bh Youdim; Silvia A Mandel
Journal:  Neurotox Res       Date:  2017-12-07       Impact factor: 3.911

6.  rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.

Authors:  Cíntia Barros Santos-Rebouças; Andressa Pereira Gonçalves; Jussara Mendonça Dos Santos; Bianca Barbosa Abdala; Luciana Branco Motta; Jerson Laks; Margarete Borges de Borges; Ana Lúcia Zuma de Rosso; João Santos Pereira; Denise Hack Nicaretta; Márcia Mattos Gonçalves Pimentel
Journal:  Neuromolecular Med       Date:  2017-05-31       Impact factor: 3.843

7.  Touchscreen typing-pattern analysis for detecting fine motor skills decline in early-stage Parkinson's disease.

Authors:  Dimitrios Iakovakis; Stelios Hadjidimitriou; Vasileios Charisis; Sevasti Bostantzopoulou; Zoe Katsarou; Leontios J Hadjileontiadis
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

8.  LRRK2 activation in idiopathic Parkinson's disease.

Authors:  Roberto Di Maio; Eric K Hoffman; Emily M Rocha; Matthew T Keeney; Laurie H Sanders; Briana R De Miranda; Alevtina Zharikov; Amber Van Laar; Antonia F Stepan; Thomas A Lanz; Julia K Kofler; Edward A Burton; Dario R Alessi; Teresa G Hastings; J Timothy Greenamyre
Journal:  Sci Transl Med       Date:  2018-07-25       Impact factor: 17.956

Review 9.  Intercellular Spread of Protein Aggregates in Neurodegenerative Disease.

Authors:  Albert A Davis; Cheryl E G Leyns; David M Holtzman
Journal:  Annu Rev Cell Dev Biol       Date:  2018-07-25       Impact factor: 13.827

10.  Neonatal C57BL/6J and parkin mice respond differently following developmental manganese exposure: Result of a high dose pilot study.

Authors:  Melanie L Foster; Thomas B Bartnikas; Hailey C Maresca-Fichter; Courtney Mercadante; Miriam Dash; Chelsea Miller; David C Dorman
Journal:  Neurotoxicology       Date:  2017-10-08       Impact factor: 4.294
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.